Search results
Nabors CFO affirms 2024 outlook at J.P. Morgan event By Investing.com
Investing.com· 2 hours agoNabors Industries Ltd. (NYSE: NYSE:NBR), a global provider of advanced technology for the energy...
CBO Raises Its 2024 Deficit Forecast 27% to Nearly $2 Trillion
The Fiscal Times via Yahoo Finance· 3 hours agoThe federal budget deficit will reach an estimated $1.9 trillion in fiscal year 2024, according to...
Mynaric AG reports preliminary 2023 results, 2024 outlook By Investing.com
Investing.com· 3 hours agoMunich-based Mynaric AG, a company specializing in communication services, disclosed its preliminary...
Gavin Stone reminds Dodgers why he might be the best Yoshinobu Yamamoto alternative
LA Times via Yahoo Sports· 40 minutes agoThe Dodgers might already have a Yoshinobu Yamamoto-caliber frontline starter in Gavin Stone, who...
Zacks Industry Outlook Highlights Enterprise Products Partners, Energy Transfer and Plains All...
Zacks via Yahoo Finance· 11 hours agoIncreased upstream activities are likely to boost demand for pipeline and storage assets, enhancing...
Could the Sky tank for Paige Bueckers? How a Dallas pick swap affects their way-too-early draft ...
Chicago Tribune· 1 hour agoAfter welcoming one of the deepest rookie classes into the league this season, the WNBA is on track...
Trump’s Campaign Message About Inflation Has the Facts Wrong
Time via AOL· 3 hours agoRomer And this falling inflation is not just matched by record low unemployment but also 2.5%...
Bird Flu Hits Texas, Kansas Milk in First Sign of Impact
Bloomberg via Yahoo Finance· 2 hours ago(Bloomberg) -- US milk production is starting to get hit by the bird flu virus, which first made the...
Canadian Banks' Ratings Affirmed by Fitch, TD Bank Outlook Cut
Zacks via Yahoo Finance· 10 hours agoFitch affirms ratings of Canadian banks - BMO, BNS, CM, TD and RY - based on stable economic...
Outlook Therapeutics, Inc.'s (NASDAQ:OTLK) largest shareholders are individual investors with 31%...
Simply Wall St. via Yahoo Finance· 1 day agoKey Insights The considerable ownership by individual investors in Outlook Therapeutics indicates...